Two-thirds of American women between 38 and 50 say they felt better prepared to go through puberty than perimenopause. The statistic, from a nationally representative survey commissioned by Flo Health and conducted by Wakefield Research, captures something that decades of public health messaging have failed to fix: most women arrive at one of the […]
The Copenhagen company says its Symphony model has outscored OpenAI on HealthBench Professional, and is offering credits and regulatory help to founders building healthcare AI worldwide. Corti, the Copenhagen-based clinical AI company, has launched a no-equity accelerator for healthcare and life sciences startups, opening its Symphony model stack to founders worldwide at a moment when […]
Bristol Myers Squibb has signed a deal worth up to 15.2 billion dollars with Jiangsu Hengrui Medicine, China’s largest pharmaceutical company by market capitalisation. The agreement covers 13 early-stage drug programmes across oncology, haematology, and immunology. None of the drugs have entered human clinical trials. The deal was announced on the same day that […]
Ditto, an Amsterdam-based health-tech building AI-generated summaries of medical appointments for patients, has raised €7.6m, the company said on Monday. The round is led by Heal Capital with participation from Rubio Impact Ventures. Earlier backer Chris Oomen, chair of Optiverder, has also participated. The funding will support expansion into Germany, the UK, and Spain this […]
Novo will take an equity stake in Cellular Intelligence and is in line for future milestone payments and royalties. The startup plans to apply its AI platform to STEM-PD, a stem-cell-derived treatment Novo discontinued last October. Novo Nordisk has handed over STEM-PD, an experimental stem-cell therapy for Parkinson’s disease, to Cellular Intelligence, an AI biotech […]
A state investigator in Pennsylvania created an account on Character.AI, opened a conversation with a chatbot called Emilie, and told it he was feeling depressed. Emilie responded that she was a psychiatrist, that she had attended Imperial College London’s medical school, that she was licensed to practise in Pennsylvania and the United Kingdom, and that […]
The pitch deck version of digital health goes something like this: AI replaces the clinician, costs drop, access expands, outcomes improve, everyone wins. The pitch has been effective. Venture capital has poured billions into companies built around the premise that removing humans from the care loop is both possible and desirable. The premise has a […]
The Belgian pharma is buying a two-year-old San Diego biotech for $2bn upfront, the second TCE bet it has placed in months. The thesis: B-cell killers built for cancer can rewire how autoimmune diseases are treated. Candid Therapeutics is two years old. It does not have an approved drug. Its lead programme has been tested […]
The company that built TikTok’s recommendation algorithm, the system that predicts with unsettling accuracy what a person wants to watch next, is now using a related class of AI to predict how molecules will behave inside a human body. ByteDance’s drug discovery unit, Anew Labs, presented its first AI-designed therapy at the American Association of […]
Most of the umbilical cord blood collected at birth is discarded. The tissue is clamped, cut, and disposed of as medical waste, along with the stem cells it contains, cells that are immunologically naive, genetically diverse, and capable of being reprogrammed into virtually any cell type in the human body. The New York Blood Center […]
